Indeed, in more than 80% of cases, infant ALL is cytogenetically characterized by balanced chromosomal translocations involving the KMT2A gene at chromosome 11q23; in contrast, those rearrangements occur in ∼5% of overall childhood ALL. The gene discussed is KMT2A; the disease is acute lymphoblastic leukemia.